Literature DB >> 21659882

Invasive bacterial infections in a paediatric emergency department in the era of the heptavalent pneumococcal conjugate vaccine.

María Herrero1, Maider Alcalde, Borja Gómez, José Luis Hernández, Mercedes Sota, Javier Benito, Santiago Mintegi.   

Abstract

OBJECTIVE: To describe the characteristics of patients diagnosed with invasive bacterial infections (IBIs) in a Paediatric Emergency Department (PED) following the introduction of the heptavalent pneumococcal conjugated vaccine (PCV7).
METHODS: Descriptive retrospective study of children under 14 years of age diagnosed with IBIs in a PED of a tertiary hospital between January 2008 and December 2009.
RESULTS: In this period we registered 123 396 episodes and 59 patients who were diagnosed with IBIs (22 patients under 1 year of age, 37.2%). Of these, 11 (18.6%) had some severe underlying condition and 38 (64.4%) were stable on arrival. The most common diagnoses were sepsis with/without meningitis (23, 38.9%) and bacteraemia (14, 23.7%), while the pathogens most frequently isolated were Streptococcus pneumoniae (23, 38.9%) and Neisseria meningitidis (18, 30.5%). Pathogens were isolated from blood in 57 patients and from the cerebrospinal fluid in eight (in these, the same bacterial species was isolated in the blood, except for two cases with S. pneumoniae). Of the pneumococci isolated, 80% corresponded to serotypes included in the 13-valent PCV13. In seven cases, pathogens were detected using only PCR analysis (N. meningitidis, four; S. pneumoniae, three). Twenty-five patients were admitted to the Paediatric Intensive Care Unit. No patient died but two had sequelae.
CONCLUSION: In the era of PCV7, pneumococcus is the leading cause of IBI in PED. The introduction of PCV13 may lead to a very significant decrease in the IBI rate and meningococcus may become the leading cause of IBI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21659882     DOI: 10.1097/MEJ.0b013e3283484bbc

Source DB:  PubMed          Journal:  Eur J Emerg Med        ISSN: 0969-9546            Impact factor:   2.799


  5 in total

1.  Factors influencing neurological outcome of children with bacterial meningitis at the emergency department.

Authors:  Fatiha Bargui; Irene D'Agostino; Patricia Mariani-Kurkdjian; Corinne Alberti; Catherine Doit; Nathalie Bellier; Laurence Morin; Giuliano Galli Gibertini; Assia Smail; Anna Zanin; Mathie Lorrot; Stéphane Dauger; Mathieu Neve; Albert Faye; Priscilla Armoogum; Antoine Bourrillon; Edouard Bingen; Jean-Christophe Mercier; Stéphane Bonacorsi; Lise E Nigrovic; Luigi Titomanlio
Journal:  Eur J Pediatr       Date:  2012-04-19       Impact factor: 3.183

Review 2.  Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis.

Authors:  Evelyn Balsells; Laurence Guillot; Harish Nair; Moe H Kyaw
Journal:  PLoS One       Date:  2017-05-09       Impact factor: 3.240

3.  Translating Sepsis-3 Criteria in Children: Prognostic Accuracy of Age-Adjusted Quick SOFA Score in Children Visiting the Emergency Department With Suspected Bacterial Infection.

Authors:  Sietske C van Nassau; Ron H van Beek; Gertjan J Driessen; Jan A Hazelzet; Herbert M van Wering; Navin P Boeddha
Journal:  Front Pediatr       Date:  2018-10-01       Impact factor: 3.418

4.  Paediatric community-acquired septic shock: results from the REPEM network study.

Authors:  P Van de Voorde; B Emerson; B Gomez; J Willems; D Yildizdas; I Iglowstein; E Kerkhof; N Mullen; C R Pinto; T Detaille; N Qureshi; J Naud; J De Dooy; R Van Lancker; A Dupont; N Boelsma; M Mor; D Walker; M Sabbe; S Hachimi-Idrissi; L Da Dalt; H Waisman; D Biarent; I Maconochie; H Moll; J Benito
Journal:  Eur J Pediatr       Date:  2013-01-26       Impact factor: 3.183

5.  Predictors of serious bacterial infections using serum biomarkers in an infant population aged 0 to 90 days: a prospective cohort study.

Authors:  Serena Su Ying Chang; Amanda Zhirui Lim; Gene Yong-Kwang Ong; Rupini Piragasam; John Carson Allen; Kee Chong Ng; Ian Maconochie; Shu-Ling Chong
Journal:  BMJ Paediatr Open       Date:  2021-01-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.